Pentax Medical is a division of HOYA Group delivering endo-imaging solutions. Pentax Medical is a globally diversified company with R&D innovation and manufacturing centres in Japan, Europe and the US. Through leading-edge optical technologies, Pentax Medical is providing the most advanced, clinically relevant endo-imaging solutions.
Pentax Medical engaged Sales Accelerant to deliver a series of pipeline qualification, decision maker database research/validation and tele-research campaigns, relating to NHS secondary care ENT, G.I. and Urology equipment and associated HCP audiences. Sales Accelerant was selected as a collaborative partner because of its healthcare industry expertise and experience, successful campaign delivery/results to date and the people employed in the team, who are each regularly trained and highly experienced and are perfectly suited to the healthcare industry decision makers successfully engaged on a daily basis, often representing global marketing leading organisations and brands, for whom reputation and image are hugely important.
Sales Accelerant has exceeded the HCP engagement level targets and more importantly in the process, over-achieved in relation to the core commercial KPIs agreed. A significant number of precious insights have been gathered across multiple campaigns and audiences, spanning the NHS nationwide; new business opportunities have been generated; pipelines validated; the CRM database of decision making contacts has been significantly enhanced and much more besides (e.g. positive company PR and customer experience enhancing feedback loop in between rep visits).
The Customer said
Sales Accelerant took away the hassle of lead generation and enabled my sales teams to concentrate on selling.
Sales Accelerant helped me by building my sales pipeline for future years so my sales teams could concentrate on closing the deals within this and next financial year.
Sales Accelerant partnered with me to deliver increased future pipeline and a happy sales team.
Pentax Medical have significantly increased investment in Sales Accelerant's services since the initial 3-month pilot and the plan is to continue the collaboration longer term.